To date, there is insufficient knowledge as to the cause of this disease, or how to prevent it. We asked some of our EH correspondents to report on measures taken in their countries to ensure that men are made more aware of this disease and whether screening services are provided for early prostate cancer detection.
A wound compress is being developed at the Hohenstein Institute in Boennigheim, Germany, that could pave the way for new treatment opportunities. The new wound compress would integrate and continually deliver effective ingredients on the basis of nanosol technology. The technique speeds up healing, simplifies treatment and reduces the amount of time required for care.
The Universities of Exeter and Bath (UK) have revealed their plans for a new world-leading research centre to explore and exploit the properties of the thinnest material in nature. The two universities have won a £5 million Science and Innovation Award from the Engineering and Physical Sciences Research Council (EPSRC) to create the Centre of Graphene Science.
Das Center for Cardiovaskular Research (CCR) an der Berliner Charité konnte sich durch vielseitige Grundlagenforschung über die deutschen Landesgrenzen hinaus bereits einen Namen machen. Nun stellt das CCR in einem aktuellen Zwischen- bericht unter anderem vielversprechende Ent- wicklungen einer neuen Medikamentenklasse bei Endorganschäden und die Erforschung der Blutgefäßbildung bei…
The 14th Eppendorf Young Investigator Award 2008, worth ?15,000, was presented at MEDICA in November.
A slow frozen pig's liver has been thawed without damage and successfully transplanted into another pig, according to Israeli scientists (initial results published in Rejuvenation Research, followed by the journal New Scientist).
Microscope designer Leica Microsystems and the European Molecular Biology Laboratory (EMBL) signed a corporate partnership agreement today whereby Leica Microsystems becomes a founder partner of the EMBL Advanced Training Centre scheduled to be completed in September 2009.
The current global financial crisis is like to hit Bio-tech and pharmaceutical companies due to a lack of funding for research and the discovery and production of many new drugs, according to Professor David Wield, Director of the Economic and Social Research Council's (ESRC) Edinburgh-based Innogen Centre, and chair of the recent international ESRC conference Genomics and Society: Reinventing…
Coronary heart disease (CHD) symptoms, presented in the context of a stressful life event, were identified as psychogenic when presented by women and organic when presented by men, which could help explain why there is often a delay in the assessment of women with CHD, according to research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) conference.
Investigating the appropriate use of procedures to open narrowed coronary arteries, e.g. angioplasty and stenting, researchers at UCSF (University of California, USA) found that less than 50% of Medicare patients had documented non-invasive stress testing prior to elective percutaneous coronary intervention, or PCI (clinical name for these procedures).
Life Science Austria (LISA) was presenting Austria's life sciences strengths at a joint exhibition stand at this year's MEDICA.
Cardiovascular risk in obese patients can be reduced up to 79% in those who undergo Roux-en-Y gastric bypass after other treatments have failed, compared with those who do not have this procedure, according to a study published in the American Journal of Cardiology (1/10/08).
NeuroNexus Technologies and Philips Research announced that they have signed a joint research agreement to develop next-generation deep brain stimulation devices with the ambition to improve the treatment of neurological diseases and psychiatric disorders.
Turning a brilliant idea into a market-ready product can be a long and arduous task. The 10th Fresenius Inventors' Fair, taking place at Medica, could make that route easier for inventors.
There is now new hope for women around the world, with the launch of an early detection test for ovarian cancer, according to HealthLinx Limited. The test, developed in Melbourne by HealthLinx scientists in collaboration with ARL Pathology, is called the OvPlex™ Panel and works by identifying whether five biomarkers (proteins) are present in a blood sample.
Since the completion of the 13-year human genome project in 2003, molecular scientists have been delving deeper into the world of cells.
Als Kongresspräsident lud Professor Stefan N. Willich von der Berliner Charité zur Diskussion über die Möglichkeit, dem Wunsch der Patienten nach integrierter medizinischer Versorgung nachzukommen. Denn bei chronischen oder Herz-Kreislauf-Erkrankungen zum Beispiel möchten die Menschen sowohl schulmedizinische Aufklärung und Behandlung durch ihren Arzt als auch…
Die erste am Universitätsklinikum Carl Gustav Carus vorgenommene Transplantation von Inselzellen aus einer Bauchspeicheldrüse verlief erfolgreich: Zwei Wochen nach dem Eingriff bildet die seit 51 Jahren an Diabetes Typ 1 erkrankte Patientin wieder körpereigenes Insulin. Die Transplantation ist Ergebnis einer über zwei Jahre dauernden, aufwendigen Aufbauarbeit an Uniklinikum und Medizinischer…
Middle ear inflammation often involves treatment with steroids and pseudo-epinephrine to reduce oedema, and antibiotics to combat primary bacterial infection or a secondary complication.
Siemens Healthcare has opened a new research centre in Cologne, where around 40 employees are developing new diagnostic tests to describe the molecular characteristics of breast cancer cells, to help physicians to select individual therapy.
The use of mammography to maintain breast health comes with a caveat: exposure of the breast to radiation, which can increase the susceptibility risk of breast cancer. Thus, using the lowest possible radiation dose for mammograms is of utmost importance.
London and Cambridge-based biopharmaceutical research firm Domainex Ltd has received a European patent for its Combinatorial Domain Hunting (CDH) Technology, which enables the cloning and expression of recombinant proteins, or parts of proteins (domains), from challenging molecular targets.
It is safe to take anticoagulants before core needle breast biopsies, according to a study performed at the Elizabeth Wende Breast Clinic in Rochester, NY.
Early suspicions of cancer, either from clinical evidence or medical imaging, are often followed up on biopsy. However, the removal of tissue for histological analysis can be uncomfortable for patients.